126 related articles for article (PubMed ID: 11504837)
1. Prognostic relevance of hMLH1, hMSH2, and BAX protein expression in endometrial carcinoma.
Peiró G; Diebold J; Mayr D; Baretton GB; Kimmig R; Schmidt M; Löhrs U
Mod Pathol; 2001 Aug; 14(8):777-83. PubMed ID: 11504837
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma.
Peiró G; Diebold J; Lohse P; Ruebsamen H; Lohse P; Baretton GB; Löhrs U
Hum Pathol; 2002 Mar; 33(3):347-54. PubMed ID: 11979377
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia: relationship with microsatellite instability.
Hardisson D; Moreno-Bueno G; Sánchez L; Sarrió D; Suárez A; Calero F; Palacios J
Mod Pathol; 2003 Nov; 16(11):1148-58. PubMed ID: 14614055
[TBL] [Abstract][Full Text] [Related]
4. BAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancers.
Miturski R; Bogusiewicz M; Tarkowski R; Ciotta C; Bignami M; Burnouf D; Jakowicki JA
Oncol Rep; 2003; 10(4):1039-43. PubMed ID: 12792767
[TBL] [Abstract][Full Text] [Related]
5. Defective mismatch repair and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG
Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202
[TBL] [Abstract][Full Text] [Related]
6. Methylation of hMLH1 in a population-based series of endometrial carcinomas.
Salvesen HB; MacDonald N; Ryan A; Iversen OE; Jacobs IJ; Akslen LA; Das S
Clin Cancer Res; 2000 Sep; 6(9):3607-13. PubMed ID: 10999752
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: associations with family history and histopathology.
Parc YR; Halling KC; Burgart LJ; McDonnell SK; Schaid DJ; Thibodeau SN; Halling AC
Int J Cancer; 2000 Apr; 86(1):60-6. PubMed ID: 10728595
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma.
Baldinu P; Cossu A; Manca A; Satta MP; Pisano M; Casula M; Dessole S; Pintus A; Tanda F; Palmieri G
Cancer; 2002 Jun; 94(12):3157-68. PubMed ID: 12115348
[TBL] [Abstract][Full Text] [Related]
9. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.
Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB
Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550
[TBL] [Abstract][Full Text] [Related]
10. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer.
Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M
Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of hMLH1 and hMSH2 protein in endometrial carcinomas with microsatellite instability.
Staebler A; Lax SF; Ellenson LH
Hum Pathol; 2000 Mar; 31(3):354-8. PubMed ID: 10746679
[TBL] [Abstract][Full Text] [Related]
12. hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas.
Xinarianos G; Liloglou T; Prime W; Maloney P; Callaghan J; Fielding P; Gosney JR; Field JK
Cancer Res; 2000 Aug; 60(15):4216-21. PubMed ID: 10945633
[TBL] [Abstract][Full Text] [Related]
13. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.
Fallik D; Borrini F; Boige V; Viguier J; Jacob S; Miquel C; Sabourin JC; Ducreux M; Praz F
Cancer Res; 2003 Sep; 63(18):5738-44. PubMed ID: 14522894
[TBL] [Abstract][Full Text] [Related]
15. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.
Samimi G; Fink D; Varki NM; Husain A; Hoskins WJ; Alberts DS; Howell SB
Clin Cancer Res; 2000 Apr; 6(4):1415-21. PubMed ID: 10778972
[TBL] [Abstract][Full Text] [Related]
16. Global DNA methylation in relation to hMLH1 and hMSH2 protein immunoreactivity in sporadic human endometrial carcinomas.
Miturski R; Postawski K; Semczuk A; Bogusiewicz M; Baranowski W; Jakowicki JA; Keith G
Int J Mol Med; 2003 May; 11(5):569-74. PubMed ID: 12684691
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability and hMLH1 and hMSH2 expression analysis in soft tissue sarcomas.
Kawaguchi K; Oda Y; Takahira T; Saito T; Yamamoto H; Kobayashi C; Tamiya S; Oda S; Iwamoto Y; Tsuneyoshi M
Oncol Rep; 2005 Feb; 13(2):241-6. PubMed ID: 15643505
[TBL] [Abstract][Full Text] [Related]
18. [Expression of hMSH2 and hMLH1 in stomach cancer and their correlation with Helicobacter pylori infection].
Ma JM; Wang ZH; Liu M; Wang M; Zhang Y; Lu S; Liu LN; Xu GW
Ai Zheng; 2004 May; 23(5):535-9. PubMed ID: 15142449
[TBL] [Abstract][Full Text] [Related]
19. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
20. Correlation between hMLH1/hMSH2 and p53 protein expression in sporadic colorectal cancer.
Park IJ; Kim HC; Kim JS; Yu ES; Yu CS; Kim JC
Hepatogastroenterology; 2005; 52(62):450-4. PubMed ID: 15816455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
